Connect with us
The EMA recommended EU approval of Waskyra, a single-dose gene therapy for patients 6 months and older with Wiskott-Aldrich syndrome who lack a suitable HSCT donor....
Half of self-care companies in Spain have AI plans, with most aiming to optimize processes, improve data use, and enhance personalization. Key obstacles include limited training,...
Spain’s Interterritorial Council approved the AI Strategy for the National Health System, a roadmap to digitalize healthcare with shared governance, unified validation of AI tools, professional...
Andalusia will invest €3.7 million over four years to expand AI tools that enhance tumor detection accuracy in hospitals across its eight provinces. Announced by President...
Eli Lilly will invest $3 billion to build a new oral medication plant in Katwijk, Netherlands, creating 500 jobs. The facility will produce treatments for obesity,...
An international team combining advanced NMR and AI has developed the SHARPER NMR technique, accelerating drug discovery tenfold. Published in the Journal of the American Chemical...
Novo Nordisk raised its bid for Metsera to €8.677 billion—11% higher than before—after Pfizer accused it of anti-competitive tactics. Metsera’s board deemed Novo’s offer a “Superior...
Pulmonary arterial hypertension (PAH) is a rare, disabling disease with complex diagnosis. MSD introduced sotatercept, Europe’s first activin signaling inhibitor for PAH, improving vascular balance and...
AI-driven multimodal diagnostics can predict heart attack risk up to 10 years before symptoms by integrating medical imaging, lab tests, and health records to assess biological...
Novartis will acquire U.S.-based Avidity Biosciences for $12 billion, expanding into advanced RNA-based therapies. The $72-per-share tender offer, a 46% premium, was unanimously approved. Avidity will...
 |
|
 |  |
 |
|